Effects of reserpine and monoamine oxidase inhibition on the levels of amino acids in sensory ganglia, sympathetic ganglia and spinal cord.
D000409:Alanine / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism*; D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism; D002415:Cats; D005725:Ganglia, Autonomic / Q000187:drug effects / Q000378:metabolism*; D005727:Ganglia, Spinal / Q000187:drug effects / Q000378:metabolism*; D005971:Glutamates / Q000378:metabolism; D005973:Glutamine / Q000378:metabolism; D005998:Glycine / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010293:Pargyline / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology*; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism*; D013233:Stellate Ganglion / Q000187:drug effects / Q000378:metabolism; D014276:Trigeminal Nerve / Q000187:drug effects / Q000378:metabolism
D000596:Amino Acids; D005971:Glutamates; D008996:Monoamine Oxidase Inhibitors; D005973:Glutamine; D001224:Aspartic Acid; D012110:Reserpine; D010293:Pargyline; D000409:Alanine; D005998:Glycine